Profile data is unavailable for this security.
About the company
Nature's Sunshine Products, Inc. is a natural health and wellness company, which markets and distributes nutritional and personal care products in more than 40 countries. The Company sells its products to a sales force of independent consultants who use the products themselves or resells them to consumers. The Company has four segments: Asia, Europe, North America, and Latin America and Other. Each of the geographic segments operates under the Natures Sunshine Products and Synergy WorldWide brands. The Latin America and Other segment include its wholesale business, in which the Company sells products to various locally managed entities, independent of the Company, that it has granted distribution rights for the relevant market. The Company's line of over 800 products includes several different product classifications, such as immune, cardiovascular, digestive, personal care, weight management and other general health products. It purchases herbs and other raw materials in bulk.
- Revenue in USD (TTM)445.32m
- Net income in USD15.08m
- Incorporated1976
- Employees814.00
- LocationNature's Sunshine Products IncSUITE 100, 2500 WEST EXECUTIVE PARKWAYLEHI 84043United StatesUSA
- Phone+1 (801) 341-7900
- Websitehttps://www.naturessunshine.com/us/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caribou Biosciences Inc | 34.48m | -102.07m | 340.50m | 158.00 | -- | 0.9051 | -- | 9.88 | -1.45 | -1.45 | 0.4675 | 4.17 | 0.0856 | -- | 17.14 | 218,208.90 | -25.33 | -- | -27.24 | -- | -- | -- | -296.05 | -- | -- | -19,343.17 | 0.00 | -- | 148.91 | -- | -2.66 | -- | -- | -- |
| Ventyx Biosciences Inc | 0.00 | -192.96m | 341.92m | 79.00 | -- | 1.18 | -- | -- | -3.29 | -3.29 | 0.00 | 4.12 | 0.00 | -- | -- | 0.00 | -59.46 | -- | -63.22 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -77.97 | -- | -- | -- |
| Ocugen Inc | 6.04m | -63.08m | 342.24m | 65.00 | -- | 8.41 | -- | 56.70 | -0.2616 | -0.2616 | 0.0247 | 0.1581 | 0.0697 | -- | -- | 92,861.54 | -72.85 | -83.56 | -91.66 | -97.79 | -- | -- | -1,045.03 | -2,921.94 | -- | -- | 0.0646 | -- | 142.60 | -- | 27.33 | -- | 39.08 | -- |
| Terns Pharmaceuticals Inc | 0.00 | -90.21m | 351.83m | 66.00 | -- | 1.38 | -- | -- | -1.27 | -1.27 | 0.00 | 3.95 | 0.00 | -- | -- | 0.00 | -32.48 | -41.34 | -33.72 | -45.70 | -- | -- | -- | -31,010.30 | -- | -- | 0.00 | -- | -- | -- | -49.49 | -- | -26.60 | -- |
| Precigen Inc | 6.23m | -95.90m | 353.47m | 202.00 | -- | 2.98 | -- | 56.78 | -0.3933 | -0.3933 | 0.0255 | 0.476 | 0.0339 | -- | 6.62 | 30,816.83 | -52.26 | -31.50 | -72.27 | -38.63 | 1.70 | 44.00 | -1,540.63 | -232.32 | -- | -- | 0.00 | -- | -76.87 | -47.16 | -20.22 | -- | -48.30 | -- |
| Nature's Sunshine Products Inc | 445.32m | 15.08m | 358.69m | 814.00 | 24.71 | 2.34 | 12.71 | 0.8055 | 0.7715 | 0.7715 | 22.78 | 8.16 | 1.86 | 1.84 | 38.84 | 547,076.20 | 6.85 | 6.57 | 10.02 | 9.41 | 72.11 | 72.69 | 3.69 | 3.74 | 1.29 | -- | 0.00 | 27.72 | 5.55 | 4.07 | 3,965.64 | -- | 16.73 | -- |
| Rani Therapeutics Holdings Inc | 0.00 | -33.97m | 360.47m | 140.00 | -- | 26.20 | -- | -- | -1.33 | -1.33 | 0.00 | 0.2729 | 0.00 | -- | -- | 0.00 | -81.81 | -- | -131.29 | -- | -- | -- | -- | -- | -- | -37.05 | 0.5359 | -- | -- | -- | -11.06 | -- | -- | -- |
| Skye Bioscience Inc | 0.00 | -37.64m | 365.38m | 11.00 | -- | -- | -- | -- | -5.69 | -5.69 | 0.00 | -0.1726 | 0.00 | -- | -- | 0.00 | -357.65 | -232.67 | -- | -- | -- | -- | -- | -- | -- | -43.27 | 1.95 | -- | -- | -- | -93.23 | -- | 23.38 | -- |
| Black Diamond Therapeutics Inc | 0.00 | -82.44m | 365.61m | 54.00 | -- | 3.08 | -- | -- | -1.92 | -1.92 | 0.00 | 2.26 | 0.00 | -- | -- | 0.00 | -52.37 | -40.29 | -58.91 | -43.29 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 9.57 | -- | -15.37 | -- |
| Harrow Inc | 130.19m | -24.41m | 367.26m | 315.00 | -- | 5.16 | -- | 2.82 | -0.7448 | -0.7448 | 3.99 | 2.01 | 0.5546 | 4.55 | 6.13 | 413,311.10 | -10.40 | -10.86 | -12.14 | -12.71 | 69.55 | 70.75 | -18.75 | -15.35 | 2.61 | 0.0445 | 0.7223 | -- | 46.95 | 25.77 | -73.30 | -- | 143.88 | -- |
| Tenaya Therapeutics Inc | 0.00 | -124.08m | 367.46m | 140.00 | -- | 2.29 | -- | -- | -1.68 | -1.68 | 0.00 | 2.04 | 0.00 | -- | -- | 0.00 | -55.21 | -- | -61.66 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -0.3388 | -- | -- | -- |
| Contineum Therapeutics Inc | 50.00m | 22.72m | 368.62m | 31.00 | 15.59 | -- | 16.06 | 7.37 | 0.9041 | 0.9041 | 1.99 | 4.96 | -- | -- | -- | 1,612,903.00 | -- | -- | -- | -- | -- | -- | 45.44 | -- | -- | -- | 0.00 | -- | -- | -- | 193.68 | -- | -- | -- |
| Jasper Therapeutics Inc | 0.00 | -64.47m | 369.90m | 45.00 | -- | 3.49 | -- | -- | -6.19 | -6.19 | 0.00 | 7.03 | 0.00 | -- | -- | 0.00 | -90.00 | -- | -104.13 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -71.06 | -- | -- | -- |
| Erasca Inc | 0.00 | -125.04m | 370.99m | 126.00 | -- | 1.02 | -- | -- | -0.8327 | -0.8327 | 0.00 | 2.10 | 0.00 | -- | -- | 0.00 | -27.48 | -- | -29.94 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 48.50 | -- | -- | -- |
| Amarin Corporation plc (ADR) | 277.46m | -52.61m | 373.71m | 275.00 | -- | 0.6846 | -- | 1.35 | -0.1288 | -0.1288 | 0.679 | 1.33 | 0.3363 | 0.4197 | 2.23 | 1,008,927.00 | -6.38 | -4.48 | -8.90 | -6.54 | 63.61 | 75.70 | -18.96 | -8.59 | 1.93 | -- | 0.00 | -- | -16.87 | 6.01 | 44.13 | -- | 55.83 | -- |
Data as of May 03 2024. Currency figures normalised to Nature's Sunshine Products Inc's reporting currency: US Dollar USD
46.58%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Wynnefield Capital, Inc.as of 31 Dec 2023 | 2.47m | 13.15% |
| Prescott Group Capital Management LLCas of 31 Dec 2023 | 1.78m | 9.48% |
| BlackRock Fund Advisorsas of 31 Dec 2023 | 748.55k | 3.98% |
| Dimensional Fund Advisors LPas of 31 Dec 2023 | 743.09k | 3.95% |
| The Vanguard Group, Inc.as of 31 Dec 2023 | 646.06k | 3.43% |
| Renaissance Technologies LLCas of 31 Dec 2023 | 554.40k | 2.95% |
| Paradigm Capital Management, Inc.as of 31 Dec 2023 | 548.20k | 2.91% |
| Wasatch Advisors, Inc.as of 31 Mar 2024 | 518.16k | 2.75% |
| Acadian Asset Management LLCas of 31 Dec 2023 | 468.47k | 2.49% |
| Geode Capital Management LLCas of 31 Dec 2023 | 282.53k | 1.50% |
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
